MOLN:NASDAQ
Molecular Partners AG
$4.04
arrow_upward
+3.69%(+0.14) 1D
Hul 20, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MOLN...
Buksan
$4.04
Mataas
$4.04
Mababa
$4.00
Mkt. cap
163.89M
Avg. na dami
7.71K
Dami
0.00
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.41
EPS
-$1.94
Beta
1.01
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Buksan
$4.04
Mataas
$4.04
Mababa
$4.00
Mkt. cap
163.89M
Avg. na dami
7.71K
Dami
0.00
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.41
EPS
-$1.94
Beta
1.01
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Mga balita at kwento
Mula sa mga source sa buong web
TipRanks
·
17 oras ang nakalipas
Molecular Partners Starts Phase 2 TACTIC Trial of MP0317 in Front-Line Cholangiocarcinoma
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
Tungkol sa Molecular Partners AG
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa